Monitoring assisted reproductive technologies in Europe is not simply a topic of academic interest, but is also a process that is necessary for safety management, demographic analysis, and health policy development. In addition, fertility treatments are increasingly contributing to natality, given the natural fertility decline and broader access to advanced technology. Therefore, we retrospectively reviewed data that were derived from the most recent European Registry for Organs, Tissues and Cells public report (EUROCET, 2012–2013) with a focus on Romanian findings. In this retrospective study, we evaluated data from Romania and various other European countries to compare the use of, and access to, assisted reproductive technologies (ART). Our findings revealed that only 224 ART cycles were accessed per million Romanian inhabitants, and that this rate was much lower than most of the other countries that we evaluated. Furthermore, ART in Romania only contributed 0.42% of the total births, compared to 1.87– 5.16% in other European countries. Based on these findings, we conclude that it is important to develop a prospective and standardized database for ART procedures in Romania, and to consider increasing access to ART (e.g., via reimbursement) to help mitigate the population decline in Romania.